AMR Action Fund
The AMR Action Fund is the world’s largest public-private partnership investing in the development of new...
Lilly 30x30 is the company's goal to create new access to quality health care for 30 million people in resource-limited settings by the year 2030. To reach that goal, we have to find new solutions across our business and with our partners.
SHOWING 5 of 20 COLLABORATIONS
See AllThe AMR Action Fund is the world’s largest public-private partnership investing in the development of new...
Global coalition to increase access to essential cancer medicines in low- and lower middle-income countries....
Pat-INFORMED, a private-public partnership between the World Intellectual Property Organisation, the...
TransCelerate is a nonprofit organization with the mission to collaborate across the biopharmaceutical...
AbbVie, Astellas Pharma Inc, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., GlaxoSmithKline, Johnson & Johnson, Merck, MSD, Pfizer Inc, Sanofi, UCBTackling the growing burden of non-communicable diseases in low and middle-income countries and supporting...
Access Accelerated, Almirall, Astellas Pharma Inc, Bayer AG, Bristol Myers Squibb, Celgene, Chiesi Farmaceutici, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., International Federation of Pharmaceutical Manufacturers & Associations, Johnson & Johnson, Menarini Group, Merck, MSD, Novartis, Pfizer Inc, Sanofi, Servier, Shionogi & Co., Ltd., Sumitomo Pharma, Takeda Pharmaceutical Company Limited, UCBSHOWING 5 of 20 COLLABORATIONS
See All